Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Melanoma 101Carcinoma, Non-Small-Cell Lung 88Carcinoma, Renal Cell 54Neoplasm Metastasis 37Squamous Cell Carcinoma of Head and Neck 32Colorectal Neoplasms 32Carcinoma, Hepatocellular 32Lung Neoplasms 31Hodgkin Disease 25Neoplasms 24Urinary Bladder Neoplasms 21Pancreatic Neoplasms 21Carcinoma, Transitional Cell 20Breast Neoplasms 19Stomach Neoplasms 17Brain Neoplasms 17Prostatic Neoplasms 16Small Cell Lung Carcinoma 15Sarcoma 15Multiple Myeloma 14Head and Neck Neoplasms 14Esophageal Neoplasms 14Glioblastoma 11Uterine Cervical Neoplasms 10Rectal Neoplasms 10Neuroendocrine Tumors 10Lymphoma 10Recurrence 9Ovarian Neoplasms 9Nasopharyngeal Carcinoma 9

Interventions

Paclitaxel 5Carboplatin 5Docetaxel 4Cisplatin 4Bevacizumab 4Taxes 3Drug Therapy 3Gemcitabine 2Fluorodeoxyglucose F18 2Cetuximab 2saracatinib 1endostar protein 1cediranib 1aflutinib 1Zoledronic Acid 1X-Rays 1Vinorelbine 1Thoracic Surgery, Video-Assisted 1Spectrum Analysis 1Silver Nitrate 1Saline Solution 1Radiotherapy, Conformal 1Radiation 1Pleurodesis 1Pemetrexed 1Nivolumab 1Naproxen 1N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea 1Morphine 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pleural Effusion, Malignant × Nivolumab × Clear all
NCT04749602 2023-03-08

Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.

Kidney Cancer Research Bureau

Phase 2 Completed
26 enrolled
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡